Nevertheless, the specific mechanism by which JSP regulates the PI3K/AKT signaling pathway via the AGE-RAGE axis remains ambiguous, necessitating further in vitro experiments and alternative methodologies to elucidate and substantiate these mechanisms and identify novel therapeutic approaches for DKD. This evidence concerns the gene AKT1 and diabetic kidney disease.